JFNIX Mutual Fund (Janus Henderson Global Life Sciences Fund Class I) is managed by Janus Henderson Investors with $717.9M in net assets. JFNIX expense ratio is 0.78%, holding 109 positions across sectors including Health Care, Unknown, Other. Inception date: 2009-07-06.

JFNIX performance shows a YTD return of 8.55%. The 1-year return is 39.51% and the 5-year return is 8.55%. JFNIX dividend yield stands at 4.21%, paid annually.

JFNIX top holdings include Eli Lilly And Company (9.7%), JOHNSON AND JOHNSON (5.6%), Astrazeneca Plc Adr (4.3%), Unitedhealth Group, Inc. (3.4%), Abbvie Inc Health Care (3.4%). View all JFNIX holdings, sector breakdown, or dividend history.

JFNIX can be compared against other funds using the overlap calculator or side-by-side comparison tool. JFNIX alternatives are available via the screener, along with tax-loss harvesting opportunities.